The First Affiliated Hospital of Zhengzhou University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

11 drugs in development

Phase 210

Preclinical1

By Therapeutic Area

top 2

Oncology

764%

Cardiovascular

19%

R&D Momentum

67/100

Pipeline Velocity

30/100

Trial Completion Rate

100/100

Pipeline Concentration

49/100

Pipeline Freshness

57/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Cardiovascular but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Oct 30, 2026

Completed

The Effect of Different Intravenous Anesthetics on Postoperative Recovery Quality in Patients Undergoing Elective Laparoscopic Colorectal Surgery: A Single-Center, Prospective, Randomized Controlled Trial

Oct 23, 2026

Active, not recruiting

A Single-arm, Prospective Phase II Clinical Study of the Efficacy and Safety of AK105 Combined With Anlotinib in the Treatment of Persistent, Recurrent, and Metastatic Cervical Cancer

Earlier

Sep 19, 2026TrialA Single-Arm, Prospective, Open-Label Clinical Study of Iparomlimab and Tuvonralimab (QL1706) Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Sep 12, 2026TrialA Prospective, Exploratory Study of Retlirafusp Alfa Combined With Famitinib and AG-Chemotherapy as First-Line Therapy for Unresectable Pancreatic Cancer

Sep 2, 2026TrialClinical Study of SHR1701 in Combination With CAPOX and SHR2554 or Apatinib for First-line Treatment of Advanced Gastric Cancer

Aug 20, 2026TrialA Prospective, Multicenter, Randomized Controlled Trial Investigating the Impact of Fasting Duration on Postoperative Rebleeding Following Esophageal Variceal Ligation.

Aug 19, 2026TrialA Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer

Aug 19, 2026TrialDevelopment and Multicenter Validation of Standardized MRI Acquisition and Structured Reporting for Primary Esophageal Squamous Cell Carcinoma: A Dual-Cohort Study of T Staging and Tumor Regression Grading

4 more events

Apr 1, 2026TrialA Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell Carcinoma

Mar 1, 2026TrialIBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer

Jan 1, 2026TrialComparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome

Dec 30, 2025TrialProspective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer